A multicentre assessment of the endogenous thrombin potential using a continuous monitoring amidolytic technique

British Journal of Haematology

Volumn 123, Issue 2, 2003, Pages 335-341

  Lawrie, Anorew S ^a   Gray, Elaine ^b   Leeming, Dave ^c   Davidson, Simon J ^d   Purdy, Gordon ^a   Iampietro, Romina ^b   Craig, Steve ^c   Rigsby, Peter ^b   Mackie, Ian J ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b NATIONAL INSTITUTE FOR BIOLOGICAL STANDARDS AND CONTROL   (United Kingdom)

^c WITHINGTON HOSPITAL   (United Kingdom)

^d ROYAL BROMPTON HOSPITAL   (United Kingdom)

Author keywords

Anticoagulation; Automation; Endogenous thrombin potential (ETP)

Indexed keywords

CHROMOGENIC SUBSTRATE; THROMBIN;

ARTICLE; AUTOANALYZER; BLOOD SAMPLING; CLINICAL LABORATORY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; GOOD CLINICAL PRACTICE; HUMAN; LABORATORY AUTOMATION; MEDICAL ASSESSMENT; MULTICENTER STUDY; PRIORITY JOURNAL; QUANTITATIVE ASSAY; STANDARDIZATION; TECHNIQUE;

ANTICOAGULANTS; BLOOD COAGULATION TESTS; CHROMOGENIC COMPOUNDS; COUMARINS; DRUG MONITORING; HEPARIN; HUMANS; INDICATORS AND REAGENTS; REPRODUCIBILITY OF RESULTS; THROMBIN;

EID: 0142246496     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.2003.04623.x     Document Type: Article

References (10)

1. Brummel, K.E., Paradis, S.G., Branda, R.F. & Mann, K.G. (2001) Oral anticoagulation thresholds. Circulation, 104, 2311-2317.
2. Hemker, H.C. & Béguin, S. (1995) Thrombin generation in plasma: its assessment via the endogenous thrombin potential. Thrombosis and Haemostasis, 74, 134-138.
3. Hemker, H.C. & Béguin, S. (1999) Endogenous thrombin potential. In: Laboratory Techiques in Thrombosis. A Manual (ed. by J. Jespersen, R.M. Bertina & F. Haverkate), pp. 63-79. Kluwer Academic Publishers, Dordrecht, The Netherlands.
4. Hemker, H.C., Wielders, S., Kessels, H. & Béguin, S. (1993) Continuous registration of thrombin generation in plasma, its use for the determination of the thrombin potential. Thrombosis and Haemostasis, 70, 617-624.
5. Kessels, H., Willems, G. & Hemker, H.C. (1994) Analysis of thrombin generation in plasma. Computers in Biology and Medicine, 24, 277-288.
6. Kher, A., Al Dieri, R., Hemker, H.C. & Béguin, S. (1997) Laboratory assessment of antithrombotic therapy: what tests and if so why? [editorial]. Haemostasis, 27, 211-218.
7. Prasa, D., Svendsen, L. & Sturzebecher, J. (1997) The ability of thrombin inhibitors to reduce the thrombin activity generated in plasma on extrinsic and intrinsic activation. Thrombosis and Haemostasis, 77, 498-503.
8. Tripodi, A., Chantarangkul, V., Clerici, M., Negri, B., Galli, M. & Mannucci, P.M. (2001) Laboratory control of oral anticoagulant treatment by the INR system in patients with the antiphospholipid syndrome and lupus anticoagulant. Results of a collaborative study involving nine commercial thromboplastins. British Journal of Haematology, 115, 672-678.
9. Wielders, S., Mukherjee, M., Michiels, J., Rijkers, D.T., Cambus, J.P., Knebel, R.W., Kakkar, V., Hemker, H.C. & Béguin, S. (1997) The routine determination of the endogenous thrombin potential, first results in different forms of hyper- and hypocoagulability. Thrombosis and Haemostasis, 77, 629-636.
10. Xi, M., Béguin, S. & Hemker, H.C. (1989) The relative importance of the factors II, VII, IX and X for the prothrombinase activity in plasma of orally anticoagulated patients. Thrombosis and Haemostasis, 62, 788-791.